SecBot SecBot

BFLY

Butterfly Network, Inc.
NYSE· X-Ray Apparatus & Tubes & Related Irradiation Apparatus· Inc. DE· CIK 0001804176 Healthcare & Medical Devices
$6.66 −0.10 (−1.48%)
Oct 26 4:00 PM ET · prev $6.76
Market cap
$1.8B
Small cap
Consensus
Buy
92% Buy or better · 13 analysts
Median target
$10.50
+58% · range $10.00–15.00
Next earnings
Oct 29
in 2 days · EPS est. −$0.03
1 year
+202.7%
from $2.20 · Oct 27
30 days
−27.2%
from $9.15
52-week range
$1.97–9.93
−33% from high · low Nov 17
Avg volume 20D
5.00M
shares / day
Short interest
🔒 Subscribers only
Insider net
−$98.8M
1 buyer · 8 sellers · since Apr 29
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
34
analyzed by SecBot
SecBot read MIXED 14 reports · 90 days
Balance 3 bearish · 2 bullish · 9 neutral oldest → newest, height = score
Avg score ·High conf. 9/14 ·Next Earnings date, Oct 29, 2026
Strongest BEARISH A mixed insider cluster at Butterfly Network shows director Robbins selling ~$20.6M across four large…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

  • S Jul 2 to Jul 22 9 days of insider sells: $59.1M by 5 insiders, avg $6.99
  • S Jul 31 to Aug 17 7 days of insider sells: $35.9M by 4 insiders, avg $8.31
  • B Aug 14 1 insider buy $999.5K at $8.68
  • R Aug 17 A mixed insider cluster at Butterfly Network shows director Robbins…
  • S Sep 2 to Sep 4 2 days of insider sells: $1.1M by 3 insiders, avg $7.31
  • S Sep 22 to Sep 23 2 days of insider sells: $59.9K by 1 insider, avg $10.01
  • S Oct 2 to Oct 6 2 days of insider sells: $447.1K by 2 insiders, avg $9.74
  • A Oct 12 Canaccord Genuity initiates

Signal stack

Where each data set points today.

  • InsidersBEARISH

    1 insider bought $999.5K at an average $8.68. 8 insiders sold $99.8M. Price is 23% below their cost.

  • InstitutionsBULLISH

    Q2 2026: 30 added (0 new), 17 trimmed or exited.

  • AnalystsBULLISH

    12 of 13 rate it Buy or better. Every target is above the price.

  • EstimatesRISING

    Current-quarter EPS estimate −$0.037 → −$0.030 over 90 days. 1 up, 0 down in 30 days.

  • TrendDOWNTREND

    19% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
Hood River Capital Management LLCADD13,190,130$111.1M
D. E. Shaw & Co., Inc.DOUBLED6,392,827$53.8M
Nuveen, LLCADD5,056,372$42.6M
FMR LLCDOUBLED4,910,388$41.3M
SEI INVESTMENTS COADD2,937,872$24.7M
GOLDMAN SACHS GROUP INCDOUBLED2,761,860$23.3M
VANGUARD PORTFOLIO MANAGEMENT LLCADD2,382,239$20.1M
MILLENNIUM MANAGEMENT LLCTRIM2,154,551$18.1M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

13 analysts
Buy 92% rate it Buy or better
Strong Buy3Buy9Hold1Sell0Strong Sell0
12-month targets · 6 analysts

Price is below the lowest target. Median implies +58%.Targets as of Oct 27, 2026.

Recent actions
DateFirmActionRating
Oct 12, 2026Canaccord Genuity
INITIATE
INITIATEBuy
Sep 29, 2026Evercore ISI Group
INITIATE
INITIATEOutperform
Sep 22, 2026Needham
INITIATE
INITIATEBuy
Sep 11, 2026TD Cowen
REITERATE
REITERATEBuy

Washington

Q3 2026
Lobbying Q3 None no reports
YoY n/a vs Q3 2025
Members 0 all time
Buys / sells 0 / 0 0 trades
Open in Washington ›

Corporate Lobbying

This company's lobbying spend, firms, issues and congressional activity are for subscribers.

Subscribe for Full Access

Insider ledger

Form 4
$999.5K
bought · 1 insider
$99.8M
sold · 8 insiders
−23.2%
vs their $8.68 cost
DateInsiderTypeValue
Oct 13, 2026
NOONEN MICHAEL
Director
AWARD37,037 sh
Oct 6, 2026
DEVIVO JOSEPH
President & CEO
SELL$358.6K
Oct 2, 2026
Carlson Megan
CAO and SVP, Finance
SELL$88.4K
Sep 23, 2026
DEVIVO JOSEPH
President & CEO
SELL$31.8K
Sep 22, 2026
DEVIVO JOSEPH
President & CEO
SELL$28.1K
Sep 4, 2026
Carlson Megan
CAO and SVP, Finance
SELL$100.8K
Sep 4, 2026
Cashman Steve
Chief Business Officer
SELL$1.0M
Sep 2, 2026
Caezza Nicholas
Deputy General Counsel
SELL$13.9K

Earnings setup

Estimates
Oct 29
reports in 2 days
−$0.03
EPS estimate, this quarter
+18%
estimate change, 90 days
1↑ 0↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.03-$0.03–-$0.03+0.0%$28.3M
Next Q🔒 Fresh data, subscribers only
Current FY-$0.09-$0.10–-$0.09-2.2%$121.7M
Next FY-$0.07-$0.10–-$0.04-35.0%$150.7M

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 15, 2026 SEC
Michael Noonen filed a Form 3 initial statement of beneficial ownership with the SEC, reporting zero shares of…
3 — Impact 2/10
Oct 13, 2026 Insider
NOONEN MICHAEL was granted 37,037 shares
Director
Oct 6, 2026 SEC
Joseph Devivo, a director and officer of Butterfly Network, Inc., filed a Form 144 notice of intent to sell 35,790…
144 — Impact 2/10
Oct 6, 2026 Insider
DEVIVO JOSEPH sold 35,790 shares
President & CEO @ $10.02 ($358.6K)
Oct 5, 2026 SEC
Butterfly Network appointed semiconductor veteran Mike Noonen to its Board of Directors, effective October 9, 2026…
8-K — Impact 3/10
Oct 2, 2026 Insider
Carlson Megan sold 10,114 shares
CAO and SVP, Finance @ $8.75 ($88.4K)
Jul 30, 2026 Earnings calendar
BFLY Q2 2026 Earnings Scheduled — 2026-07-30
Jun 30, 2026 Inst.
Hood River Capital Management — ADD
13,190,130 shares ($111.1M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Oct 29, 2026
Earnings date
BFLY Q3 2026 Earnings Before Market Open — 2026-10-29
Recent
Jul 30, 2026
Earnings date
BFLY Q2 2026 Earnings Scheduled — 2026-07-30
Apr 30, 2026
Earnings date
BFLY Q1 2026 Earnings Scheduled — 2026-04-30
Feb 26, 2026
Earnings date
BFLY Q4 2025 Earnings Before Market Open — 2026-02-26

SecBot reports

34 filings · 3 bullish · 15 bearish · 16 neutral
All BFLY filing & press-release reports (34)